The Kidney and Hypertension in Diabetes Mellitus, Sixth Edition

BOOK COVER......Page 1
TITILE......Page 4
COPYRIGHT......Page 5
CONTENTS......Page 6
PREFACE to the first edition......Page 10
PREFACE to the second edition......Page 12
PREFACE to the third edition......Page 14
PREFACE to the fourth edition......Page 15
PREFACE to the fifth edition......Page 16
PREFACE to the sixth edition......Page 17
Contributors......Page 18
1 RATIONALE FOR EARLY SCREENING FOR DIABETIC KIDNEY DISEASE......Page 24
2 PRESSURE-INDUCED AND METABOLIC ALTERATIONS IN THE GLOMERULUS: CYTOSKELETAL CHANGES......Page 36
3 THE STENO HYPOTHESIS FOR CARDIOVASCULAR AND RENAL DISEASE REVISITED......Page 50
4 MICROALBUMINURIA AND CARDIOVASCULAR DISEASE......Page 68
5 THE HEART IN DIABETES: RESULTS OF TRIALS......Page 86
6 MICROALBUMINURIA AND GFR IN TYPE 1 AND TYPE 2 DIABETES......Page 100
7 SERUM CREATININE AND OTHER MEASURES OF GFR IN DIABETES......Page 130
8 FAMILIAL FACTORS IN DIABETIC NEPHROPATHY......Page 140
9 GENETICS AND DIABETIC NEPHROPATHY......Page 152
10 LOW BIRTH WEIGHT AND DIABETIC NEPHROPATHY......Page 172
11 EFFECTS OF INSULIN ON THE CARDIOVASCULAR SYSTEM AND THE KIDNEY......Page 186
12 VALUE OF SCREENING FOR MICROALBUMINURIA IN PATIENTS WITH DIABETES MELLITUS AS WELL AS IN THE GENERAL POPULATION......Page 204
13 DYSFUNCTION OF THE VASCULAR ENDOTHELIUM AND THE DEVELOPMENT OF RENAL AND VASCULAR COMPLICATIONS IN DIABETES......Page 220
14 PATHOGENESIS AND MANAGEMENT OF BACTERIAL URINARY TRACT INFECTIONS IN ADULT PATIENTS WITH DIABETES MELLITUS......Page 246
15 PATHOLOGY OF THE KIDNEY IN DIABETES MELLITUS......Page 264
16 RENAL STRUCTURAL CHANGES IN PATIENTS WITH TYPE 1 DIABETES AND MICROALBUMINURIA......Page 278
17 RENAL STRUCTURE IN TYPE 2 DIABETES......Page 294
18 NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS, PREDICTORS OF OUTCOME......Page 310
19 ADVANCED GLYCATION END-PRODUCTS AND DIABETIC RENAL DISEASE......Page 326
20 PROTEIN KINASE C ACTIVATION AND ITS INHIBITION FOR THE TREATMENT OF DIABETIC RENAL PATHOLOGIES......Page 346
21 BIOCHEMICAL ASPECTS OF DIABETIC NEPHROPATHY......Page 364
22 PATHOGENESIS OF DIABETIC GLOMERULOPATHY: THE ROLE OF GLOMERULAR HEMODYNAMIC FACTORS......Page 386
23 THE EMERGING ROLE OF GROWTH HORMONE (GH) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN DIABETIC KIDNEY DISEASE......Page 406
24 TRANSFORMING GROWTH FACTOR-β AND OTHER CYTOKINES IN EXPERIMENTAL AND HUMAN DIABETIC NEPHROPATHY......Page 420
25 BLOOD PRESSURE ELEVATION IN DIABETES: THE RESULTS FROM 24-h AMBULATORY BLOOD PRESSURE RECORDINGS......Page 456
26 MICROALBUMINURIA IN YOUNG PATIENTS WITH TYPE 1 DIABETES......Page 480
27 EARLY RENAL HYPERFUNCTION AND HYPERTROPHY IN IDDM, INCLUDING COMMENTS ON EARLY INTERVENTION......Page 502
28 AUTOREGULATION OF GLOMERULAR FILTRATION RATE IN PATIENTS WITH DIABETES......Page 518
29 THE ROLE OF RENAL BIOPSY IN THE CLINIC......Page 538
30 INHIBITION OF THE RENIN ANGIOTENSIN ALDOSTERONE SYSTEM, WITH PARTICULAR REFERENCE TO THE DUAL BLOCKADE PRINCIPLE......Page 550
31 THE CONCEPT OF INCIPIENT DIABETIC NEPHROPATHY AND THE EFFECT OF EARLY ANTIHYPERTENSIVE INTERVENTION......Page 564
32 THE ROLE OF PROTEINURIA IN THE DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES......Page 578
33 ANTIHYPERTENSIVE TREATMENT IN TYPE 2 DIABETES, WITH SPECIAL REFERENCE TO ABNORMAL ALBUMINURIA: A FOCUS ON THE NEW TRIALS......Page 602
34 BLOOD PRESSURE LOWERING TREATMENT AND THE PREVENTION OF STROKE IN THE DIABETIC PATIENT......Page 634
35 NON-GLYCAEMIC INTERVENTION IN DIABETIC NEPHROPATHY: THE ROLE OF DIETARY PROTEIN AND SALT INTAKE......Page 654
36 DIABETIC NEPHROPATHY AND PREGNANCY......Page 670
37 EVOLUTION WORLDWIDE OF RENAL REPLACEMENT THERAPY IN DIABETES......Page 710
38 HEMODIALYSIS AND CAPD IN TYPE 1 AND TYPE 2 DIABETIC PATIENTS WITH ENDSTAGE RENAL FAILURE......Page 726
39 KIDNEY AND PANCREAS TRANSPLANTS IN DIABETES......Page 748
40 COMBINATION THERAPY FOR HYPERTENSION AND RENAL DISEASE IN DIABETES......Page 790
41 MICROALBUMINURIA IN ESSENTIAL HYPERTENSION: CARDIOVASCULAR AND RENAL IMPLICATIONS......Page 808
42 A COMPARISON OF PROGRESSION IN DIABETIC AND NON-DIABETIC RENAL DISEASE: SIMILARITY OF PROGRESSION PROMOTERS......Page 824
43 SCIENTIFIC BASIS FOR NEW GUIDELINES FOR THE TREATMENT OF HYPERTENSION IN TYPE 2 DIABETES......Page 844
44 REGULATORY CONSIDERATIONS IN THE DEVELOPMENT OF THERAPIES FOR DIABETIC NEPHROPATHY AND RELATED CONDITIONS......Page 860
45 DIABETES, HYPERTENSION,AND KIDNEY DISEASE IN THE PIMA INDIANS.......Page 880
46 THE DEVELOPMENT AND PROGRESSION OF CLINICAL NEPHROPATHY IN WHITE PATIENTS WITH TYPE 2 DIABETES......Page 894
47 MICROALBUMINURIA, BLOOD PRESSURE AND DIABETIC RENAL DISEASE: ORIGIN AND DEVELOPMENT OF IDEAS......Page 906